The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the Cleveland Clinic identified key factors influencing long-term weight loss in patients with obesity who were prescribed injectable semaglutide or liraglutide for treating type 2 diabetes or obesity. The research was published in JAMA Network Open. “In patients with obesity […]
Source link
